Pfizer, as a global organisation, collaborates with scientists, technicians, regulatory professionals and business experts across the world, including those in the UK, to find and develop the next generation of innovative medicines for patients.

As part of our approach, we also work with other innovators across the health landscape including academic scientists, patient organisations, governments, other biopharmaceutical companies and healthcare professionals.

We focus our efforts in core areas where we are best positioned to develop medicines and vaccines for conditions with significant unmet need. This includes cardiovascular and metabolic disease, chronic inflammatory and autoimmune diseases, infectious diseases, oncology, pain, and rare diseases.